financetom
Business
financetom
/
Business
/
Honeywell International Names Mike Stepniak CFO
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Honeywell International Names Mike Stepniak CFO
Sep 6, 2024 12:53 PM

06:51 AM EDT, 09/05/2024 (MT Newswires) -- Honeywell International ( HON ) said Thursday it has named Mike Stepniak, vice president and chief financial officer for Honeywell Aerospace Technologies, as senior vice president and chief financial officer.

Stepniak, who will be appointed CFO after the announcement of the company's Q4 results, succeeds Greg Lewis, who will become senior vice president of Honeywell Accelerator and serve as a senior advisor to Chairman and Chief Executive Vimal Kapur.

Stepniak has previously served as chief financial officer of Honeywell Building Technologies and in positions at General Electric (GE) and Baker Hughes.

Price: 205.94, Change: +0.40, Percent Change: +0.19

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-Grocery Outlet Holding Corp Closes Acquisition Of United Grocery Outlet
BRIEF-Grocery Outlet Holding Corp Closes Acquisition Of United Grocery Outlet
Apr 2, 2024
April 2 (Reuters) - Grocery Outlet Holding Corp ( GO ): * GROCERY OUTLET HOLDING CORP. ( GO ) CLOSES ACQUISITION OF UNITED GROCERY OUTLET Source text for Eikon: Further company coverage: ...
Verve Therapeutics pauses enrollment in early-stage gene therapy study for high cholesterol levels
Verve Therapeutics pauses enrollment in early-stage gene therapy study for high cholesterol levels
Apr 2, 2024
April 2 (Reuters) - Verve Therapeutics ( VERV ) said on Tuesday that it had paused enrollment for an early-stage study testing its experimental gene editing therapy for high cholesterol after a patient experienced a severe drug-related adverse event. The company was testing the therapy in patients with a genetic condition that leads to high cholesterol levels, which raises the...
BRIEF-Accenture To Acquire Intellera Consulting
BRIEF-Accenture To Acquire Intellera Consulting
Apr 2, 2024
April 2 (Reuters) - Accenture PLC ( ACN ): * ACCENTURE TO ENHANCE DIGITAL TRANSFORMATION CAPABILITIES FOR ITALY'S PUBLIC SECTOR WITH ACQUISITION OF INTELLERA CONSULTING * ACCENTURE PLC ( ACN ): HAS AGREED TO ACQUIRE INTELLERA CONSULTING Source text for Eikon: Further company coverage: ...
Roivant's anti-inflammatory drug succeeds in mid-stage study
Roivant's anti-inflammatory drug succeeds in mid-stage study
Apr 2, 2024
By Bhanvi Satija April 2 (Reuters) - Roivant Sciences ( ROIV ) said on Tuesday its experimental drug to treat non-infectious uveitis helped reduce symptoms of the inflammatory eye disease in a mid-stage study. In the study testing 26 patients, 29% of those who received a higher-strength 45 milligram (mg) dose and 44% of those who received a 15 mg...
Copyright 2023-2026 - www.financetom.com All Rights Reserved